5 ASX 200 shares rocketing to new 52-week highs on Tuesday

This year has brought good tidings to the S&P/ASX 200 Index (ASX: XJO) and these five shares are among those making the most of it.

They’ve each jumped as much as 5.8% to reach their highest point in more than a year on Tuesday.

Meanwhile, the iconic index is up 0.44% at 7,490.4 points at the time of writing. That’s 7.8% higher than it was at the start of the year.

Let’s take a closer look at what’s sent these market giants soaring today.

These ASX 200 shares are roaring to long-forgotten heights

The first ASX 200 share posting a new 52-week high is Clinuvel Pharmaceuticals Limited (ASX: CUV). Stock in the biopharmaceutical developer lifted 2.6% to reach $27.42 earlier today – the highest it’s been since 2021.

It follows yesterday’s news of the company’s analogue adrenocorticotropic hormone (ACTH). It’s aiming to submit a regulatory drug master file for the product in the second half of this year – an “aggressive goal” according to chief scientific officer Dr Dennis Wright.

The Mineral Resources Ltd (ASX: MIN) share price is also rocketing on Tuesday, hitting a new record high amid a broker upgrade. The stock peaked at $96.78 earlier today – a 5.8% gain.

UBS has reportedly upped its expectations for lithium. It now tips demand to outweigh supply in the near and medium term, the Australian Financial Review reports.

In response, it’s slapped a buy rating on shares in the ASX 200 materials giant.

Meanwhile, the TechnologyOne Ltd (ASX: TNE) share price is in the green for a third consecutive day. It follows the release of the company’s non-price-sensitive annual report on Thursday evening.

The tech stock reached an all-time high of $14.705 today – marking a 2% rise.

ASX 200 travel giant Webjet Limited (ASX: WEB), on the other hand, popped then dropped today, hitting a post-pandemic high of $6.86 this morning before plunging into the red.

Today’s peak saw the stock 1.2% higher than its previous close and around 170% higher than its 2020 low.

Finally, shares in ASX 200 health imaging technology provider Pro Medicus Limited (ASX: PME) have continued to inch towards their all-time high today.

The stock has posted a new 52-week high for a third consecutive session. This time it peaked at $64.77 – a 2.4% jump.

Its gains might be a belated reaction to Friday’s announcement, detailing a $25 million contract with the University of Washington.  

The post 5 ASX 200 shares rocketing to new 52-week highs on Tuesday appeared first on The Motley Fool Australia.

(function() {
function setButtonColorDefaults(param, property, defaultValue) {
if( !param || !param.includes(‘#’)) {
var button = document.getElementsByClassName(“pitch-snippet”)[0].getElementsByClassName(“pitch-button”)[0];
button.style[property] = defaultValue;
}
}

setButtonColorDefaults(“#0095C8”, ‘background’, ‘#5FA85D’);
setButtonColorDefaults(“#0095C8”, ‘border-color’, ‘#43A24A’);
setButtonColorDefaults(“#fff”, ‘color’, ‘#fff’);
})()

More reading

• Up 30% in six months: Can the Webjet share price fly even higher?
• Why a merger between Fortescue and this major-league miner could make sense: expert
• This ASX 200 healthcare share just hit a new 52-week high. Here’s why
• My top predictions for ASX lithium shares in 2023
• My top predictions for ASX 200 mining shares in 2023

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Pro Medicus. The Motley Fool Australia has recommended Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

from The Motley Fool Australia https://ift.tt/0JAGuvi